Showing 1 - 5 results of 5 for search 'Leonardo Flenghi', query time: 0.02s Refine Results
  1. 1
    Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax

    Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax by Vincenzo Maria Perriello, Lorenza Falini, Loredana Ruggeri, Daniele Sorcini, Stelvio Ballanti, Leonardo Flenghi, Nicodemo Baffa, Piero Covarelli, Paolo Sportoletti, Antonio Pierini, Brunangelo Falini

    Published 2023-05-01
    Get full text
    Article
  2. 2
    Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement

    Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement by Simonetta Saldi, Vincenzo Maria Perriello, Lorenza Falini, Loredana Ruggeri, Christian Fulcheri, Sara Ciardelli, Alessandra Innocente, Stelvio Ballanti, Nicodemo Baffa, Leonardo Flenghi, Antonio Pierini, Cynthia Aristei, Brunangelo Falini

    Published 2022-07-01
    Get full text
    Article
  3. 3
    P1208: TRANSCRIPTOMIC PROFILING OF B CELL STATES AND MICROENVIROMENTAL ECOSYSTEMS REFINES THE PROGNOSTIC CLASSIFICATION OF DIFFUSE LARGE B CELL LYMPHOMA

    P1208: TRANSCRIPTOMIC PROFILING OF B CELL STATES AND MICROENVIROMENTAL ECOSYSTEMS REFINES THE PROGNOSTIC CLASSIFICATION OF DIFFUSE LARGE B CELL LYMPHOMA by Robel Papotti, Filippo Vit, Federico Pozzo, Tamara Bittolo, Stefania Bettelli, Samantha Pozzi, Antonino Maiorana, Elisa Forti, Arianna DI Napoli, Maria Christina Cox, Tamar Tadmor, Giovanna Mansueto, Pellegrino Musto, Leonardo Flenghi, Martina Quintini, Vittoria Lalinga, Sara Galimberti, Valentina Donati, Michele Spina, Alberto Zamò, Andreas Rosenwald, Riccardo Bomben, Stefano Sacchi, Valter Gattei

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy

    Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy by Lisa Argnani, Alessandro Broccoli, Cinzia Pellegrini, Alberto Fabbri, Benedetta Puccini, Riccardo Bruna, Maria Chiara Tisi, Francesco Masia, Leonardo Flenghi, Maria Elena Nizzoli, Maurizio Musso, Marilena Salerno, Potito Rosario Scalzulli, Daniela Dessi’, Isacco Ferrarini, Elsa Pennese, Elisa Lucchini, Francesca Gaia Rossi, Carla Minoia, Filippo Gherlinzoni, Pellegrino Musto, Caterina Patti, Vittorio Stefoni, Pier Luigi Zinzani

    Published 2022-12-01
    Get full text
    Article
  5. 5
    MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)

    MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL) by Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, Cristina Tecchio, Giuseppe Carli, Mattia Novo, Piero Maria Stefani, Sara Rattotti, Monica Balzarotti, Dario Marino, Matteo Pelosini, Alessandra Romano, Leonardo Flenghi, Vittorio Ruggero Zilioli, Teresa Calimeri, Arianna Di Napoli, Manuela Zanni, Erica Finolezzi, Federico Mosna, Guido Gini, Giovanna Mansueto, Alice Di Rocco, Gabriella Tomei, Nicola Sgherza, Jacopo Olivieri, Luca Nassi, Francesco Piazza, Angelo Fama, Antonio Greco, Margherita Giannoccaro, Anna Maria Mazzone, Carlo Visco, Giacomo Loseto, Francesco Zaja, on behalf of the Fondazione Italiana Linfomi Postgraduate Master course

    Published 2019-12-01
    Get full text
    Article

Search Tools: